Home to leading manufacturers, robotics pioneers, infrastructure builders and iconic gaming companies, of course, Japan is one of the world’s centers of AI — building across the full stack with NVIDIA technologies. This week NVIDIA and its partners in Japan are showcasing the AI ecosystem’s latest advancements. Check back here for updates. Wednesday, July 15, 4 p.m. PT 🔗 Japan’s Leaders Advance Healthcare and Life Sciences With NVIDIA Agentic and Physical AI Japan built the world’s most trusted names in medical technology and biopharma. Now the country’s healthcare leaders are engineering the next generational leap with AI, powered by NVIDIA. From autonomous surgical robots to AI-accelerated CT systems, and from agentic drug discovery platforms to virtual cell models, Japanese innovators are deploying NVIDIA technology to reshape medicine at every level. Agentic AI Accelerates Japanese Drug Discovery Japan’s pharmaceutical leaders are uniting around AI-powered drug discovery. Tokyo-1, the AI drug discovery consortium and platform operated by Xeureka, continues to expand, with Eisai joining this past April, bringing together leading pharma companies — Astellas, Daiichi Sankyo and Ono Pharmaceuticals — all advancing drug discovery using NVIDIA BioNeMo. Astellas has deployed nearly all BioNeMo NIM microservices within NVIDIA’s digital biology portfolio and is running BioNeMo Agent Toolkit, NVIDIA’s open platform that turns any AI agent into an autonomous life sciences scientist. It gives AI agents, software platforms and biopharma systems immediate access to NVIDIA’s full life sciences stack. Ono Pharmaceuticals is using the Boltz-2 NIM microservice to streamline and accelerate internal drug discovery. Daiichi Sankyo is conducting ultralarge-scale virtual screening on Tokyo-1 and leveraging NVIDIA RAPIDS to accelerate large-scale data processing. Xeureka is using NVIDIA BioNeMo to power its AI-driven drug discovery efforts, enabling researchers the flexibility to use the most appropriate models and tools across diverse discovery programs. SyntheticGestalt announced two products: